Prospects for low dose BCG vaccination against tuberculosis

Area of Science:

• Immunology
• Vaccinology
• Infectious Diseases

Background:

• Vaccination typically induces rapid immunity against fast-growing pathogens.
• Chronic diseases caused by slow-growing pathogens may require cell-mediated immunity (CMI) for containment.
• Some infections, like leishmaniasis, can induce an antibody response at the expense of protective CMI.

Purpose of the Study:

• To develop a general strategy for imprinting the immune system to ensure a stable, protective CMI response upon natural infection.
• To investigate a method to overcome non-protective antibody responses in susceptible individuals.

Main Methods:

• Utilizing BALB/c mice, susceptible to Leishmania major, as a model system.
• Exposing mice to low doses of Leishmania major to induce CMI.
• Challenging previously exposed mice with a pathogenic dose to assess protective immunity.

Main Results:

• Low-dose Leishmania major infection induced only cellular immunity and established a protective imprint in mice.
• Mice exposed to low doses and later challenged with a high dose mounted a stable, protective CMI response.
• This low-dose exposure strategy successfully protected susceptible mice against progressive disease.

Conclusions:

• A general strategy exists to imprint the immune system for a stable, protective CMI response.
• Low-dose exposure can be a method to induce protective CMI against pathogens causing chronic diseases.
• This approach shows promise for improving vaccination efficacy in diseases like leishmaniasis and tuberculosis.